abstract Quality measures are used for a variety of purposes in health care, including clinical care improvement, regulation, accreditation, public reporting, surveillance, and maintenance of certifi cation. Most quality measures are 1 of 3 types: structure, process, or outcome. Health care quality measures should address the domains of quality across the continuum of care and refl ect patient and family experience. Measure development for pediatric health care has a number of important challenges, including gaps in the evidence base; the fact that measures for most conditions must be agespecifi c; the long, resource-intensive development process; and the national focus on measure development for adult conditions. Numerous national organizations focus on the development and application of quality measures, including the Pediatric Quality Measures Program, which is focused solely on the development and implementation of pediatric-specifi c measures. Once a quality measure is developed for use in national measurement programs, the organization that develops and/or "stewards" the measure may submit the measure or set of measures for endorsement, which is recognition of the scientifi c soundness, usability, and relevance of the measure. Quality measures must then be disseminated and applied to improve care. Although pediatric health care providers and child health care institutions alike must continually balance time and resources needed to address multiple reporting requirements, quality measurement is an important tool for advancing high-quality and safe health care for children. This policy statement provides an overview of quality measurement and describes the opportunities for pediatric health care providers to apply quality measures to improve clinical quality and performance in the delivery of pediatric health care services.
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INTRODUCTION
The American Academy of Pediatrics (AAP) and its members are committed to the highest-quality and safest health care for infants, children, adolescents, and young adults. Quality measurement is a critical tool for improving health care quality and patient safety. Quality measures are used for a variety of purposes, including improvements in clinical care, regulation, accreditation, public reporting, surveillance, and maintenance of certification (MOC) programs. In addition, the federal government and other payers are shifting to payment programs linked to quality, such as accountable care organizations (ACOs) and patientcentered medical homes, making it increasingly important that pediatric health care providers understand and implement quality measurement into clinical care processes.
The emerging focus on value in health care to address rising costs and to ensure desirable patient outcomes has led to a rapid increase in the development of quality measures. 1 Although the development of pediatric-specific quality measures has intensified, it has not kept pace with the number and breadth of quality measures applicable to adults. Much of the focus and resources allocated to the development of quality measures have been, and continue to be, targeted toward the adult population, which accounts for most of the nation's health care spending. The result has been relatively small investments in child health quality measure development. Although some measures may be applicable to both children and adults, it is important that all involved in the implementation of quality measures, such as national policy makers, health care organizations, payers, physician organizations, and pediatric health care providers, understand that measures that are appropriate for adults may not be suitable for children. It is useful to think about the unique considerations for children compared with adults as the 5 Ds: developmental change, dependency, differential epidemiology, demography, and dollars (differences in financing of child health services). 2, 3 These differences are important when developing, choosing, and implementing quality measures. Another consideration for increasing the investment in child health measures is that many adult conditions begin during childhood, and therefore, early identification and intervention can lead to improvements in child health care quality and potentially can have significant positive effects on lifelong health combined with reductions in long-term health care costs. This policy statement provides an overview of quality measurement and describes opportunities for pediatric health care providers to apply quality measures to improve clinical quality and performance in the delivery of pediatric health care services.
TYPES OF QUALITY MEASURES
To understand how measures are applied to children, it is useful to understand the types of quality measures. Quality measures are "tools that help us measure or quantify health care processes, outcomes, patient perceptions, and organizational structure and/or systems that are associated with the ability to provide high-quality health care." 4, 5 The Institute of Medicine specified 6 key domains or targets for improving health care quality: safety, timeliness, effectiveness, efficiency, equity, and patient/ family centeredness. 4 In addition, the components of the "Triple Aim" (http:// www. ihi. org/ engage/ initiatives/ tripleaim/ Pages/ default. aspx), improving patient experience, improving the health of populations, and reducing the per capita cost of health care, should be incorporated in measurement frameworks. Health care quality measures should address the domains of quality across the continuum of care and reflect patient and family experiences. Measures can be specific to conditions (eg, treatment of asthma in children) or cut across conditions, such as measures focused on coordination of care or hospital readmission. Preventive care, management of acute conditions, and increasingly, long-term and end-of-life issues as well as the transition from 1 site of care or 1 provider to another also should be included in pediatric quality-measurement frameworks.
Although many quality measures are available, most are categorized into 1 of 3 measure types: structure, process, or outcomes. 6 Structural measures assess "sufficiency of resources and proper system design, " including organizational characteristics, such as the type of care provided (eg, primary or specialty) and the use of specific systems for improving care (eg, an electronic health record or registry). 7 Process measures assess the interaction between the patient (and/or his or her family) and the practitioner. 6 Specifically, process measures assess the way in which care and services are provided, including assessment, evaluation, diagnosis, and treatment (eg, prescribing an asthma-control medication for a child with chronic asthma, provision of private confidential one-on-one screening and counseling to adolescents). Process includes the extent to which the patient is able to access needed health care services and the practitioner's use of standardized assessments. Outcome measures assess the effect of care delivered on the patient's (and family's) health and function. Outcome measures may reflect immediate outcomes, such as the proportion of immunized patients; intermediate outcomes, such as the number of visits to the emergency department for asthma attacks; or long-term outcomes, such as permanent disability or death. Another outcome measure includes patient-reported outcomes, which increasingly are recognized as an important component of a qualitymeasurement program. Patientreported outcome measures include any report of the status of a patient's health condition that comes directly from the patient (or family) without interpretation of the patient's response by a practitioner or anyone else. 8, 9 The inclusion of the patient and family perspective regarding the delivery of health care is important in framing the pediatric approach to quality.
Quality measures do not have a hierarchy. Although an outcome measure may be ideal in some circumstances, process and structural measures also are important in assessing a patient's care, especially when the process or structure is proven to be critical to the patient's outcome. With regard to children, in many cases, outcome measures may not be useful, because adverse outcomes are rare and therefore are applicable to a narrow population of children with serious chronic disease. For that reason, process measures that are more closely linked to improving outcomes on the basis of available evidence, such as those assessing preventive care and counseling, may be more relevant to children and youth and may be easier and less costly to use.
DEVELOPMENT AND ENDORSEMENT OF QUALITY MEASURES
The quality-measure development process involves a number of key steps, which can take months or even years to complete. Alternatively, the process could begin with an already established evidence-based guideline. Otherwise, the process generally begins with an evidence review to identify and prioritize measure topics. The next steps include an environmental scan of the literature to determine whether measures exist, development of draft measure specifications, testing of draft measures, endorsement of measures, implementation, and continual feedback from stakeholders ( Fig 1) . 10, 11 The development process is designed to assess a measure's importance, scientific soundness, feasibility, and usability. Moreover, as part of the development process, stakeholder input is critical in determining measures concepts and in prioritizing them. Stakeholders should include patients or family members, health care practitioners, and payers to ensure that all views are gathered from groups affected by quality measures. Once the measure topic area is determined to be important, developers begin the process of measure specification and testing. The components of measure specification include denominator, numerator, exclusions, data sources, and technical specifications to ensure proper implementation. Testing of the measure takes place to determine its validity and reliability, which entail determining whether the measure is scientifically sound and feasible to use. In addition, it is critical that data sources are available to extract the data used in the measure. 11 Data sources include administrative data (eg, health insurance claims data), disease registries, health records (paper or electronic), and qualitative data (eg, some types of patient surveys). Some data sources are easier to obtain and use than others; therefore, when developing measures, the accessibility of data for that measure or set of measures is an important consideration. Finally, stewardship of measures is an important component in the measurement process. Measure stewards maintain and refine measures to ensure that technical specifications remain up to date. Measure stewards may or may not also be measure developers. There are various models delineating the qualitymeasures development process that are similar. The American Medical Association Physician Consortium for Performance Improvement model (Fig 1) shows that the development process is a cycle. The cycle often starts with a review of the evidence and gaps, proceeds to measure development/ enhancement and specification, and then moves to testing; and depending on the intended use of the measure, the measure may be endorsed by a national organization. After implementation, feedback and evaluation are important to determine the usefulness and validity of the measure.
Numerous national organizations focus on the development of pediatric quality measures. The federal government is a significant funder of health care qualitymeasure development. A variety of public-private organizations and academic institutions also develop pediatric quality measures. Organizations that develop a significant number of measures include the American Medical Association's Physician Consortium for Performance Improvement, the National Committee for Quality Assurance (NCQA), the Accreditation Association for Ambulatory Health Care, and the Utilization Review Accreditation Commission (URAC). The NCQA develops the measures that >90% of private insurers use. 12 The NCQA, a membership organization that includes most health plans, develops measures and certifies health plans on the basis of their performance by using its Healthcare Effectiveness Data and Information Set (HEDIS). HEDIS measure sets include measures applicable to children as well as child-specific quality and performance measures. 12 The only national program focused solely on pediatric-specific measure development and implementation is the Pediatric Quality Measures Program (PQMP).
Title IV of the Children's Health Insurance Program Reauthorization Act (CHIPRA) of 2009 focused on a number of provisions to improve quality of care for children in Medicaid, including establishing the PQMP to (1) develop a portfolio of publicly available, new, and enhanced evidence-based pediatric quality measures for use by Medicaid/ Children's Health Insurance Program (CHIP) and other public and private programs and (2) provide opportunities to improve and strengthen the Child Core Set (CCS).
Since 2011, the Agency for Healthcare Research and Quality, in partnership with the Centers for Medicare and Medicaid Services (CMS), has worked to fulfill the PQMP provisions. 13 Seven PQMP Centers of Excellence (COEs) were funded (through 2016) to develop a broad range of measures and methodologies that fill previous gaps in child health care quality measurement. The primary domains for measure development included perinatal/prenatal health, preventive services, patient-reported outcomes, and the management of chronic and acute conditions. Completed measures may be considered for future updates to the CCS of quality measures reported on by state Medicaid/CHIP or for other publicprivate uses.
Once a measure is developed for use in national measurement programs, the organization that develops or "stewards" the measure may submit the measure or set of measures for endorsement. The National Quality Forum (NQF), a nonpartisan publicprivate organization, serves as the primary measure-endorsement body nationally. The NQF convenes the Measure Applications Partnership, which provides input to the US Department of Health and Human Services (DHHS) on the selection of quality measures for public reporting, evaluating performance, and supporting value-based programs. 14 The NQF endorsement process includes broad participation from various health care stakeholders, including health care professionals, consumers, public and private purchasers, employers, hospitals, health plans, and other organizations involved in health care research or quality improvement, including the AAP. The NQF evaluates proposed measures to ensure that they are "evidence-based, important to making significant gains in health care quality, and improving health outcomes for a specific high-priority (high-impact) aspect of health care where there is variation in or overall less-than-optimal performance." 15 Many CMS reporting programs prioritize the use of NQF-endorsed measures; however, many other rigorously developed measures are available and appropriate for use by health care practices and institutional quality-improvement programs.
MULTIPLE USES FOR QUALITY MEASURES Quality Measures for Clinical Improvement
A variety of quality measures are used at the practice or institutional level to improve and monitor quality of the health care services delivered. Domains most frequently measured in health care settings include
FIGURE 1
Quality measure development process. (Reprinted with permission from American Medical Association. Physician Consortium for Performance Improvement. Measure development process. Available at: http:// www. ama-assn. org/ ama/ pub/ physician-resources/ physician-consortium-performance-improvement/ pcpi-measures/ about-measure-development/ process. page. 10 Copyright © 1995-2015 American Medical Association.) EHR, electronic health record; PCPI, Physician Consortium for Performance Improvement; QI, quality improvement.
process of care (timely and efficient), outcomes (effective), safety, and patient experience (patient centered and equitable). 16, 17 Measures should be selected to reflect the attributes and goals of the practice or institution, and their outcomes should be compared with national and regional benchmarks to help determine improvement activities. Pediatric health care providers also can identify areas for improvement within their practices by using tools such as the Plan-Do-Study-Act cycle. 18, 19 Measurement is used to determine whether the practice change has resulted in improvement. Pediatric health care providers planning on integrating quality improvement into their practices can learn how to do so by accessing resources shown in Table 1 Table 1 for a list of easily accessible inventories of validated pediatric measures for local qualityimprovement activities.)
In addition, as many small and solo groups merge into clinically integrated networks, it is increasingly important that these practices show that they are providing value to payers by measuring clinical outcomes. A foundation of quality measures and quality improvement supports the development of large, clinically integrated networks, and the recent advent of value-based care by both private and public payers will accelerate the need for appropriate pediatric measures. 
Quality Measures for Payment
The Affordable Care Act (ACA) provided access to health insurance for millions of Americans. In fact, Medicaid, CHIP, or private insurance now covers almost 95% of children. The ACA has also facilitated the implementation of new payment models intended to improve the quality of care while reducing costs for families. In January 2015, the Secretary of the DHHS announced that it "intends to focus its energies on… using incentives to motivate higher value care, by increasingly tying payment to value through alternative payment models…." 32 Furthermore, the DHHS announced new goals for its payment programs, including that 85% of all Medicare fee-for-service payments will be tied to quality or value by 2016, and this number will increase to 90% by 2018. Although these goals are specific to the Medicare program, The DHHS also is encouraging state Medicaid programs and private payers to make progress toward increasing the use of value-based payments. Section 2713 of the Affordable Care Act allows the Secretary of the DHHS to establish guidelines to permit health insurance plans to use value-based insurance designs. 33 Defining and measuring value are challenging. Value is related to the cost and quality of care, which include patient outcomes and patient satisfaction. Value-based payment models aim to increase health care quality while decreasing costs. These programs accomplish this by tying payment incentives (or disincentives) to goals and measurement. The CMS defines value-based payment as holding "health care providers accountable for both the cost and quality of care they provide. It attempts to reduce inappropriate care and to identify and reward the best-performing providers." 34 Porter 35 defines value in health care as "the patient health outcomes achieved per dollar spent, " and furthermore, "value should define the framework for performance improvement in health care. Rigorous, disciplined measurement and improvement of value is the best way to drive system progress." In the context of child health, Forrest and Silber 36 described dimensions of value that include outcomes, patient (or family)-reported outcomes, financial cost to family, and financial cost to society. These dimensions can be assessed at the individual level or the systems level. Value-based measures are a nascent concept, and frameworks have been proposed for the development of pediatric value measures.
Alternatives to the current feefor-service model of payment being promoted and implemented by the DHHS and private payers include ACOs, episodes-of-care payments, and global payments to health care providers. ACOs are networks of providers with unified governance that assume risk for the cost and quality of the care they deliver. 37 ACOs are designed to reduce medical costs by monitoring care across multiple care settings, including physician practices, clinics, emergency departments, and hospitals, and they hold providers accountable for the quality and overall cost of the care provided. 38 Providers are given spending targets, and if costs to care for patients are less than the target, the providers share in the savings. ACOs theoretically incentivize providers to choose the most effective and efficient care for patients. In fact, cost savings must be achieved while maintaining or improving quality, so setting limits on utilization alone would not be acceptable. Episode-of-care payments or bundled payments are single payments for a group of services related to a treatment or condition that may involve multiple providers in multiple settings as opposed to fee for service with reimbursement for each service during the course of treatment. 39 Furthermore, additional payments are not made for complications that may occur during treatment. Providers share any savings if the cost of the care is below a target amount. Bundled payments incentivize practitioners to reduce unnecessary tests and visits and to improve processes with the aim of reducing complications related to care. 40, 41 The challenge with this payment design for pediatric patients is that, unlike acute illnesses and conditions, many chronic pediatric conditions do not have discrete dates of onset and no resolution. Global payments are fixed prepayments made to providers or a health care institution or system that cover most or all of a patient's care during a specified time period. Instead of each provider receiving payments, they are paid as a group, which theoretically creates more cooperation, coordination, and accountability among providers. 42 Global payments are similar to episode-of-care payments, but the difference is that global payments are made for a group of patients, such as enrollees in a health plan, and cover all care that is covered by the health plan.
The CMS has developed a framework for progression of payment reform for practitioners and health care organizations from traditional fee for service, to fee for service with a link to quality and other alternate payment models, including accountable care, medical homes, and global payments. 43 All of the models except for the fee-for-service model require quality measurement and reporting. Moreover, private insurers and state Medicaid programs are implementing these newer models, and therefore, pediatric health care providers should understand the role of quality measurement within these payment schemes to navigate successfully through these payment programs.
LIMITATIONS AND CHALLENGES RELATED TO THE DEVELOPMENT AND IMPLEMENTATION OF QUALITY MEASURES
Developing pediatric-specific and pediatric-relevant quality measures involves a number of challenges.
There is a relative paucity of evidence in the pediatric scientific literature supporting the best diagnostic approach and management of pediatric conditions. In addition, quality-measure development is an expensive and time-consuming process, and without a sustained funding source to support development, implementation, and stewardship, the pipeline of pediatric quality measures likely will be considerably reduced. The MACRA only extends CHIP and PQMP funding through September 2017. 
RECOMMENDATIONS
For general pediatric health care providers and pediatric medical subspecialists:
1. Assess your practice's or institution's readiness to engage in quality-improvement activities, starting with identification of areas for improvement and learning about health care quality and quality measurement (see Table 1 for resources).
2. Champion quality measurement and quality improvement in your practice and within your institutions.
3. Consider investing in educating yourself and your practice on the science of quality improvement and measurement. Use existing resources and educational opportunities that will allow successful participation in changing payment models.
4. Consider engaging families and adolescents in the process of determining priority areas for practice improvement.
5. Consider setting qualityimprovement goals for your practice and use quality measures to track progress. Understand the population served by your practice/clinic/institution to more meaningfully prioritize quality-improvement goals and measurement and to allocate resources more effectively.
6. Consider participating in collaborative improvement networks.
7. Consider participating in advocacy activities on behalf of pediatric health care quality.
For national policy makers: 
